Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.

Xirouchakis, E., Sigalas, A., Manousou, P., Calvaruso, V., Pleguezuelo, M., Corbani, A., et al. (2008). Models for non-alcoholic fatty liver disease: a link with vascular risk. CURRENT PHARMACEUTICAL DESIGN, 2008.

Models for non-alcoholic fatty liver disease: a link with vascular risk.

CALVARUSO, Vincenza;
2008-01-01

Abstract

Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.
2008
Xirouchakis, E., Sigalas, A., Manousou, P., Calvaruso, V., Pleguezuelo, M., Corbani, A., et al. (2008). Models for non-alcoholic fatty liver disease: a link with vascular risk. CURRENT PHARMACEUTICAL DESIGN, 2008.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/44659
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? ND
social impact